Based on our findings, we now re-define the IL-1β transgenic mouse as a unique dual model that can be utilized to simultaneously study both inflammation-driven ESCC (plus oral SCC) and GEJ metaplasia/adenocarcinoma. The gene discussed is IL1B; the disease is adenocarcinoma.